← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Human Cell Co
Naperville, IL
$4,057,357
Total funding
7
Grants
Funding over time
peak $1.7M · FY2017–24$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,057,357 · 7
By mechanism
R43$2,084,777 · 6
R44$1,972,580 · 1
Investigators at Human Cell Co
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Optimizing NGF for Topical Treatment of Glaucoma$991,520
R44 · FY2024 · EY
Optimizing NGF for Topical Treatment of Glaucoma$981,060
R44 · FY2023 · EY
Optimization of TIL Cell Manufacturing for Cancer Treatment$400,000
R43 · FY2023 · CA
Topical treatment of an optimized NGF for Dry Eye$365,000
R43 · FY2024 · EY
Topical NGF Therapy and oral nicotinamide supplementation for Glaucoma$360,897
R43 · FY2024 · EY
tPA and NGF therapy for stroke$359,500
R43 · FY2021 · NS
Optimizing NGF for Topical Treatment of Glaucoma$299,805
R43 · FY2017 · EY
Recombinant Prothrombin Therapy for Hemorrhage$299,575
R43 · FY2017 · HL